A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients
Clinical trial NCT00249171 · COMPLETED
Trial details
- NCT number
- NCT00249171
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-06-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.